AI-based classification and outcome prediction in BCR::ABLI-like B-cell precursor acute lymphoblastic leukemia patients using targeted RNA-seq


Por: Rosa-Rosa, JM, Ribera, J, Morgades, M, Granada, I, Diaz, RA, Barrera, S, Hernandez-Sanchez, A, Acosta, JDN, Garcia, MH, Such, E, Torrent, A, Coll, R, Cervera, M, Artigal, CM, Rivas, JMH, Orfao, A, Ribera, JM, Martinez-Lopez, J and Sanchez, R

Publicada: 3 nov 2025 Ahead of Print: 1 nov 2025
Resumen:


Filiaciones:
Rosa-Rosa, JM:
 Hosp Univ 12 Octubre, Inst Investigacibn Hosp Octubre i 12, Hematol Malignancies Clin Res Unit, Hematol Dept,CNIO, Madrid, Spain

Ribera, J:
 Josep Carreras Leukemia Res Inst, Badalona, Spain

 Hosp Germans Trias i Pujol, Hematol Dept, ICO Badalona, Barcelona, Spain

 ICO Badalona, Hematol Dept, Badalona, Spain

 CIBERONC ISCIII, Madrid, Spain

Morgades, M:
 Hosp Germans Trias i Pujol, Hematol Dept, ICO Badalona, Barcelona, Spain

 ICO Badalona, Hematol Dept, Badalona, Spain

 CIBERONC ISCIII, Madrid, Spain

:
 Hosp Germans Trias i Pujol, Hematol Dept, ICO Badalona, Barcelona, Spain

 ICO Badalona, Hematol Dept, Badalona, Spain

 CIBERONC ISCIII, Madrid, Spain

Diaz, RA:
 Hosp Univ 12 Octubre, Inst Investigacibn Hosp Octubre i 12, Hematol Malignancies Clin Res Unit, Hematol Dept,CNIO, Madrid, Spain

Barrera, S:
 CIBERONC ISCIII, Madrid, Spain

 Univ Salamanca, Canc Res Ctr IBMCC, Translat & Clin Res Program, CSIC, Salamanca, Spain

 Cytometry Serv, NUCLEUS, Salamanca, Spain

 Univ Salamanca, Dept Med, IBSAL, Salamanca, Spain

Hernandez-Sanchez, A:
 Hosp Univ Salamanca, Ctr Investigacibn Canc, Hematol Dept, IBSAL,IBMCC,CSIC, Salamanca, Spain

Acosta, JDN:
 Hosp Univ Salamanca, Ctr Investigacibn Canc, Hematol Dept, IBSAL,IBMCC,CSIC, Salamanca, Spain

Garcia, MH:
 CIBERONC ISCIII, Madrid, Spain

 Univ Salamanca, Canc Res Ctr IBMCC, Translat & Clin Res Program, CSIC, Salamanca, Spain

 Cytometry Serv, NUCLEUS, Salamanca, Spain

 Univ Salamanca, Dept Med, IBSAL, Salamanca, Spain

Such, E:
 Hosp Univ & Politecn La Fe, Hematol Dept, Valencia, Spain

Torrent, A:
 Josep Carreras Leukemia Res Inst, Badalona, Spain

 Hosp Germans Trias i Pujol, Hematol Dept, ICO Badalona, Barcelona, Spain

 ICO Badalona, Hematol Dept, Badalona, Spain

 CIBERONC ISCIII, Madrid, Spain

Coll, R:
 ICO Hosp Univ Doctor Josep Trueta, Hematol Dept, Girona, Spain

Cervera, M:
 ICO Hosp Univ Joan XXIII, Hematol Dept, Tarragona, Spain

Artigal, CM:
 Hematol Dept, ICO Duran & Reynals, Lhospitalet De Llobregat, Barcelona, Spain

Rivas, JMH:
 Hosp Univ Salamanca, Ctr Investigacibn Canc, Hematol Dept, IBSAL,IBMCC,CSIC, Salamanca, Spain

Orfao, A:
 CIBERONC ISCIII, Madrid, Spain

 Univ Salamanca, Canc Res Ctr IBMCC, Translat & Clin Res Program, CSIC, Salamanca, Spain

 Cytometry Serv, NUCLEUS, Salamanca, Spain

 Univ Salamanca, Dept Med, IBSAL, Salamanca, Spain

:
 Josep Carreras Leukemia Res Inst, Badalona, Spain

 Hosp Germans Trias i Pujol, Hematol Dept, ICO Badalona, Barcelona, Spain

 ICO Badalona, Hematol Dept, Badalona, Spain

 CIBERONC ISCIII, Madrid, Spain

Martinez-Lopez, J:
 Hosp Univ 12 Octubre, Inst Investigacibn Hosp Octubre i 12, Hematol Malignancies Clin Res Unit, Hematol Dept,CNIO, Madrid, Spain

Sanchez, R:
 Hosp Univ 12 Octubre, Inst Investigacibn Hosp Octubre i 12, Hematol Malignancies Clin Res Unit, Hematol Dept,CNIO, Madrid, Spain
ISSN: 00064971





Blood
Editorial
American Society of Hematology, 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA, Estados Unidos America
Tipo de documento: Meeting Abstract
Volumen: 146 Número:
Páginas: 4358-4359
WOS Id: 001663416200008
imagen Bronze

MÉTRICAS